Please login to the form below

Living with NASH: An Unexpected Diagnosis

Published in eyeforpharma November 2017 by Mariel Metcalfe

With no current licensed treatments and more than 20 compounds in phase II and III, the liver disease non-alcoholic steatohepatitis (NASH) represents a huge opportunity for pharma companies – if they understand patient needs.

As our waistlines thicken and our activity levels decrease, another chronic illness threatens to disturb our comfortable lifestyles. And, because it’s relatively unknown, diagnosis comes as a shock to patients, who usually associate liver disease with heavy consumption of alcohol...

Read the full article: 
https://www.researchpartnership.com/news/2017/11/living-with-nash-an-unexpected-diagnosis/


1st December 2017

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change.
Research Partnership
News:
Senior Analytics Specialist joins Research Partnership
Research Partnership
Article:
All change – how untangling human behaviour can encourage better health
Research Partnership
Webinar:
Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy
Research Partnership
News:
Therapy Watch COVID-19 tracker
Research Partnership
Events:
Patient Centricity and Engagement Conference 2021
Research Partnership